01.22.16
Cenveo, Inc. announced that it has completed the previously disclosed sale of its Packaging Business to WestRock. The company also reported expected results for the three months and year ended Jan. 2, 2016. The results are both preliminary and unaudited, and may be adjusted as a result of, among other things, completion of customary financial close review and independent audit procedures.
The company expects preliminary net sales for the fourth quarter 2015 to be at least $470 million, compared to net sales of $453 million during the same period in 2014. For the full year 2015, the company expects net sales to be approximately $1.74 billion compared to $1.76 billion for the prior year. The company also expects adjusted EBITDA for the full year to be near the high end of the previously issued guidance of between $153 and $160 million. The expected results exclude the operations of the Packaging Business, as it has been classified in the company’s consolidated financial statements as discontinued operations.
“We are pleased not only to complete the sale of our Packaging Business to WestRock, but also with our expected operating results for the fourth quarter,” said Robert G. Burton Sr., chairman and CEO. “We saw solid performances by each of our operations, highlighted by continued margin expansion in our envelope segment as compared to the prior year. Additionally, we ended 2015 in an improved liquidity position, reflecting our cash flow generation capability during the last three months of the year.”
The company also announced that on Jan. 19, 2016, it received notice from the New York Stock Exchange, Inc. (NYSE) that it does not presently satisfy the NYSE’s continued listing standard requiring the average closing price of the company’s common stock to be at least $1.00 per share for 30 consecutive trading days. The notice has no immediate impact on the listing of the company’s common stock. In accordance with the NYSE rules, the company will respond to the notice within 10 business days of its receipt as to how Cenveo intends to cure the deficiency and return to full compliance with the NYSE continued listing standards.
“While the recent significant volatility across the global financial markets along with other factors has negatively impacted our share price, we remain confident that our plan will create value over the long term,” Burton said. “The completion of the sale of the Packaging Business and our stronger fourth quarter results were important pieces to that plan and reflect some of the momentum that we are seeing towards achieving that plan.”
The company expects preliminary net sales for the fourth quarter 2015 to be at least $470 million, compared to net sales of $453 million during the same period in 2014. For the full year 2015, the company expects net sales to be approximately $1.74 billion compared to $1.76 billion for the prior year. The company also expects adjusted EBITDA for the full year to be near the high end of the previously issued guidance of between $153 and $160 million. The expected results exclude the operations of the Packaging Business, as it has been classified in the company’s consolidated financial statements as discontinued operations.
“We are pleased not only to complete the sale of our Packaging Business to WestRock, but also with our expected operating results for the fourth quarter,” said Robert G. Burton Sr., chairman and CEO. “We saw solid performances by each of our operations, highlighted by continued margin expansion in our envelope segment as compared to the prior year. Additionally, we ended 2015 in an improved liquidity position, reflecting our cash flow generation capability during the last three months of the year.”
The company also announced that on Jan. 19, 2016, it received notice from the New York Stock Exchange, Inc. (NYSE) that it does not presently satisfy the NYSE’s continued listing standard requiring the average closing price of the company’s common stock to be at least $1.00 per share for 30 consecutive trading days. The notice has no immediate impact on the listing of the company’s common stock. In accordance with the NYSE rules, the company will respond to the notice within 10 business days of its receipt as to how Cenveo intends to cure the deficiency and return to full compliance with the NYSE continued listing standards.
“While the recent significant volatility across the global financial markets along with other factors has negatively impacted our share price, we remain confident that our plan will create value over the long term,” Burton said. “The completion of the sale of the Packaging Business and our stronger fourth quarter results were important pieces to that plan and reflect some of the momentum that we are seeing towards achieving that plan.”